Current Advances in Inherited Retinal Disease
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: 25 December 2025 | Viewed by 123
Special Issue Editor
Interests: inherited retinal diseases; retinal artery occlusion; age-related macular degeneration; biosimilars; diabetic retinopathy; ocular drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Inherited retinal disease (IRD) is a major cause of bilateral visual decline and blindness worldwide. To date, there is no definitive treatment option for this condition. Recently, there have been advances in the field of genetic diagnosis, and new treatment methods have been introduced, including gene therapy and genome editing. Since the approval of gene therapy for RPE65-related IRD, the future of IRD treatment appears bright, and more patients with IRD may be saved from blindness as more advanced technology is developed. To achieve better visual outcomes for IRD patients, a greater understanding of IRD, including genetics, mechanisms, clinical features, and preclinical and clinical trial results related to the conditions, is needed by physicians, researchers, and patients alike, as well as by pharmaceutical companies and governments.
For this Special Issue, we welcome reviews and original articles on the study of IRD. Potential topics include, but are not limited to, the genetic and molecular mechanisms behind IRD, diagnosis, clinical features and imaging in IRD cases, epidemiology, ethnic variability, preclinical research, and clinical trials to develop new treatments. We look forward to receiving your contributions.
Prof. Dr. Se Joon Woo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inherited retinal diseases
- retinitis pigmentosa
- macular dystrophy
- cone dystrophy
- genotype
- gene therapy
- clinical trial
- imaging
- genetic mechanism
- genome editing
- phenotype
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
